[Form 4] Stryker Corporation Insider Trading Activity

Rhea-AI Filing Summary

Insider transaction summary: Stryker Corporation director and Group President Viju Menon reported a sale of 500 shares of Stryker common stock on 08/25/2025 at a reported price of $390.61 per share. After the sale, Mr. Menon beneficially owns 12,511 shares directly and 197 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 08/27/2025.

Insights

Corporate Governance Expert

TL;DR: Routine insider sale disclosed; ownership remains concentrated with a modest reduction in direct holdings.

This Form 4 records a straightforward sale by an executive-level insider. The sale of 500 shares at $390.61 reduced direct beneficial ownership to 12,511 shares while 197 shares remain held indirectly via a 401(k). There is no accompanying derivative activity or indication of a Rule 10b5-1 plan in the filing. As presented, the disclosure is routine and compliant, providing transparency about the insider's post-transaction holdings.

Securities Analyst

TL;DR: Single small disposal reported; transaction size appears immaterial to company capitalization.

The filing documents a single disposition of 500 common shares by a reporting officer. The transaction price is stated as $390.61 per share and the filing shows remaining direct and indirect holdings. No options, grants, or derivative positions are disclosed. From a market-impact perspective, the sale is small relative to typical public-company float and contains no additional contextual details.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Menon Viju

(Last) (First) (Middle)

1941 STRYKER WAY

(Street)

PORTAGE MI 49002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group President

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		S		500	D	$390.61	12,511	D
Common Stock								197	I	By 401K

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24, Power of Attorney, is attached.

	/s/ Austin Y. Ke, attorney-in-fact for Viju Menon	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Viju Menon report on the Form 4 for SYK?

The Form 4 reports a sale of 500 shares of Stryker common stock on 08/25/2025 at a price of $390.61 per share.

How many Stryker shares does Viju Menon beneficially own after the reported transaction?

After the reported sale, Mr. Menon beneficially owns 12,511 shares directly and 197 shares indirectly through a 401(k) plan.

Was any derivative or option activity disclosed in this Form 4 for SYK?

No derivative securities, options, or convertible instruments are disclosed in the filing; only non-derivative common stock ownership and the sale are reported.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Austin Y. Ke, attorney-in-fact for Viju Menon, with a signature date of 08/27/2025.

Does the Form 4 indicate whether the sale was made under a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan; no such plan mention appears in the provided content.